Resources Contact Us Home
Ribonucleotide reductase inhibitors and methods of use

Image Number 18 for United States Patent #8372983.

Provided herein are novel compounds that inhibit ribonucleotide reductase (RR) by binding to RRM2 and interfering with the activity of the RRM1/RRM2 holoenzyme, as well as methods of synthesizing these novel compounds. The compounds may be used to inhibit RR activity and to treat various conditions associated with RRM2 expression, such as for example certain cancer types, mitochondrial diseases, or degenerative diseases.

  Recently Added Patents
Newly identified human rhinovirus of HRV-C and methods and kits for detecting HRV-Cs
Wire guide
System for the secure management of digitally controlled locks, operating by means of crypto acoustic credentials
Computer system for routing package deliveries
Registration and network access control
Light fixture
Collaborative image capture
  Randomly Featured Patents
Electrical field display/signal device
Distortion precompensator and method of compensating for distortion in a transmission medium
Self-adjusting utility plier
Apparatus and method for routing packets in a network
Liquid crystal display device
Urinary catheter assembly allowing for non-contaminated insertion of the catheter into a urinary canal
Copyright protection system for data storage and transmission
Package board having internal terminal interconnection and semiconductor package employing the same
Method and/or system for providing and/or analyzing influence strategies
Compounds which inhibit complement and/or suppress immune activity